-
Likelihood of Approval and Phase Transition Success Rate Model - INexin in Corneal Ulcers
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INexin in Corneal Ulcers report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INexin in Corneal Ulcers Drug Details: iNexin is under development for...
-
Likelihood of Approval and Phase Transition Success Rate Model - DST-2105 in Keratoconjunctivitis Sicca (Dry Eye)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DST-2105 in Keratoconjunctivitis Sicca (Dry Eye) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DST-2105 in Keratoconjunctivitis Sicca (Dry Eye) Drug Details: DST-2105...
-
Likelihood of Approval and Phase Transition Success Rate Model - Anti-CDH17 CAR-T Cells in Biliary Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Anti-CDH17 CAR-T Cells in Biliary Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anti-CDH17 CAR-T Cells in Biliary Tumor Drug Details: The...
-
Likelihood of Approval and Phase Transition Success Rate Model - DCR-PDL1 in Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - DCR-PDL1 in Non-Hodgkin Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. DCR-PDL1 in Non-Hodgkin Lymphoma Drug Details: The therapeutic candidate is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - SCAR-02 in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SCAR-02 in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SCAR-02 in Systemic Sclerosis (Scleroderma) Drug Details: SCAR-02 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - KLS-1 in Metastatic Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - KLS-1 in Metastatic Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. KLS-1 in Metastatic Pancreatic Cancer Drug Details: KLS-1 is under...
-
Likelihood of Approval and Phase Transition Success Rate Model - Verenafusp Alfa in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome )
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Verenafusp Alfa in Mucopolysaccharidosis II (MPS II) (Hunter Syndrome ) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Verenafusp Alfa in Mucopolysaccharidosis II...
-
Likelihood of Approval and Phase Transition Success Rate Model - ATH-399A in Parkinson's Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATH-399A in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATH-399A in Parkinson's Disease Drug Details: ATH-399A is under investigation for...
-
Likelihood of Approval and Phase Transition Success Rate Model - Molnupiravir in Unspecified Influenza Virus Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Molnupiravir in Unspecified Influenza Virus Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Molnupiravir in Unspecified Influenza Virus Infections Drug Details: Molnupiravir...
-
Likelihood of Approval and Phase Transition Success Rate Model - PVX-4 in Cervical Intraepithelial Neoplasia (CIN)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PVX-4 in Cervical Intraepithelial Neoplasia (CIN) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PVX-4 in Cervical Intraepithelial Neoplasia (CIN) Drug Details: PVX-4...